remogliflozin: the most studied sglt2i on indian t2dm patients by dr. l.k.muskara
Published 12 days ago • No plays • LengthDownload video MP4
Download video MP3
Similar videos
-
remogliflozine: the most studied sglt2i in indian t2dm patients by dr suddhasatwa ghosh
-
6:57
how does dapagliflozin work? understanding sglt2 inhibitors.
-
8:15
sglt2 inhibitors and heart failure
-
3:35
risdiplam clinical trial data
-
5:14
risk for heart failure modulate the effectiveness of empagliflozin ?
-
1:01
introducing pain medicine specialist schuyler rogg, m.d., m.b.a.
-
3:57
aha 2019: empagliflozin on erythropoietin levels – dr david mazer
-
57:56
modern treatment of type 2 diabetes when to use sglt2 inhibitors, dpp 4 inhibitors and glp ras
-
1:22
medicine 998 d 1047 felty's syndrome ra rheumatoid arthritis liver complication lymphadenopathy
-
4:46
understanding rheumatological diseases - more than just aches and pains
-
1:00
what your post-meal glucose levels can tell you | dr. rob lustig, md
-
11:26
itamar raz, md: impact of dapagliflozin on fast decline in egfr
-
5:36
ai future of sacroiliitis assessment
-
5:22
gut feels with dr ganesh - gerd (gastroesophageal reflux disease)
-
5:33
rfpi multispectral physiologic visualization
-
3:09
aptei: pain education #2/ explaining radiological findings
-
0:17
learn about cortisol curves and fatigue